Lv02
0 积分 2026-06-03 加入
Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a network meta-analysis of population-based cohort studies
1小时前
待确认
Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
1小时前
待确认
Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials
1小时前
已完结
.Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials
1小时前
已完结
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2个月前
已完结
Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
2个月前
已完结
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
2个月前
已完结
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
2个月前
已完结
皖公网安备34019202002308
